Eyecarrot Website  |  About  |  Platforms                                                         Get FinancialNewsMedia.com Alerts 

Privacy Policy

Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) Breaking News
July 19, 2018

 

EYECARROT SECURES DISTRIBUTION DEAL WITH AUSTRALASIA’S LEADING BEHAVIORAL OPTOMETRIC ORGANIZATION ACBO
 

ACBO  = AUSTRALASIAN COLLEGE OF BEHAVIOURAL OPTOMETRISTS


Toronto, Ontario --July 19, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce it has secured a distribution deal with the leading Australasian Behavioural Optometric group ACBO (“The Australasian College of Behavioural Optometrists”). Eyecarrot recently attended the 8th International Congress of Behavioural Optometry in Sydney where the Binovi Platform was very well received. The company will now work with ACBO to follow through on its first shipment of 40 Binovi Touch units into the Australasian marketplace.

“ACBO has been the leading group of Behavioural Optometrists in Australasia for many decades now and is an incredibly well-run organization. Our Binovi Platform was incredibly well received in our recent trip to Sydney and we have prioritized shipment of units to that region later this summer. We are excited to be working with ACBO and the ability to extend our platform globally and expect to penetrate the Australasian market with hundreds of units”. Commented CEO Adam Cegielski.

About The Australasian College of Behavioural Optometrists
The Australasian College of Behavioural Optometrists (ACBO) was founded in 1987, and provides Australian, New Zealand and Asian Optometrists with education and training in behavioural optometry. Its members have special interest in children’s vision, patients with learning difficulties, traumatic brain injury, binocular vision dysfunction, as well as those wishing to enhance their visual skills. ACBO is the professional association for independent optometrists who wish to differentiate themselves by focusing on functional vision care, neurodevelopmental optometry and vision therapy.

About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp

 

EYECARROT SECURES DISTRIBUTION DEAL WITH BERNELL FOR 1000 BINOVI TOUCH UNITS


Toronto, Ontario --June 27, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce it has secured a distribution deal with the world’s leading vision distribution organization Bernell Corporation (“Bernell”). The first 150 units, US$450,000 revenue, will be delivered within 60 days. Eyecarrot’s Binovi Touch Saccadic Fixator will be available through Bernell and is showcased on the cover of their 2018 catalogue. This partnership will help the company replace the existing 5000 analog units currently in North America.

“We are excited to secure a partnership with the leading ophthalmic distributor for our Binovi Touch Saccadic Fixator. After completing our initial beta testing, and now shipping our first 100 units, we will work together with Bernell to distribute our next 1000 units into the marketplace while expanding our reach into new markets, globally. This represents the first of many distribution agreements which we expect to announce in the coming months.” Commented CEO Adam Cegielski.

The Company has also granted an aggregate of 500,000 options to Directors, Officers, Employees, and Consultants, having a two (2) year term and exercisable at a price of $0.20 per share.

About Bernell

The Bernell Corporation was founded by Dr. Bernard Vodnoy and his wife Nellie in 1954. The company has evolved to provide over 2,000 ophthalmic products. Bernell is proud to offer the largest assortment of Vision Training, Enhancement, and Rehabilitation products in the world. In 2012, Bernell was presented with the distinguished Industry Appreciation Award by the American Optometric Association for their work and contributions to the field of Sports Vision. Bernell sells over 2,000 ophthalmic products to optometrists, ophthalmologists, occupational therapists, schools and government around the world. They carry a wide range of products to meet the primary care and vision testing needs of its customers, as well as the largest line of vision therapy, visual rehabilitation, and behavioral optometry products in the world.

About Eyecarrot

Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp

 

EYECARROT TEAMS UP WITH UC BERKELEY, THE STATE UNIVERSITY OF NEW YORK AND FLORIDA STATE UNIVERSITY FURTHERING THE REACH OF THE BINOVI TOUCH VISION PERFORMANCE PLATFORM


Toronto, Ontario --June 21, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce that it has initiated delivery of the Binovi Touch Saccadic Fixator to some of the top Academic Institutions in North America. The company is now working with leading vision researchers from universities in the United States such a University of California Berkeley, The State University of New York (SUNY), and Florida State University to accelerate use of the Binovi Platform in developing further research in human vision performance gains.

“Our company has moved from conceptual design, to now fulfilling shipments to World Class Institutions in the United States in under 24 months. We can now accelerate further expansion into the market and extend the reach of our Binovi Touch globally.” Stated CEO Adam Cegielski.

The company has now shipped 100 units of the Binovi Touch vision performance hardware since release 2 months ago. This represents a year over year growth in unit sales of over 500% since 2017 The company continues to receive significant interest and increase in sales while showcasing its hardware at the 48th Annual College of Optometrists in Vision Development Meeting.

“Recent feedback from the maret has emphasized the utility of the Binovi Touch, as our customers are using the product every day and on every patient. We are pleased with this increase in demand, and overall reception of our platform. Optometrists are appreciating the expanded feature sets, their therapy teams are embracing the modernization, and their patients are thrilled with overall performance. Our next steps are working towards increasing production and carrying inventory of our flagship product with the intent of replacing the 5,000 analog models currently in the market.” Commented CEO Adam Cegielski.

Key differentiating features of the device can be found below:

• 49 tactile responsive buttons, multi-colored button options
• 4 LED Matrix displays
• Bluetooth connectivity through the Binovi Touch mobile app
• Secure data connectivity to our Microsoft Azure API
• Modular design that allows for scaling the size of the device
• Weight of approximately 14kg (smallest and most robust in the market)
• A price point that allows for accessibility in almost any vertical market imaginable
• Research documenting the importance of saccadic eye movements will now increase by orders of magnitude with the release of a data connected Binovi Touch Saccadic Fixator

About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors

Adam Cegielski
President | CEO

Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp

 

Eyecarrot Attends 121st American Optometric Association Meeting in Denver Colorado, to Showcase the Binovi Touch in Sports and Performance Vision Forum


Toronto, Ontario --June 19, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce its participation at the 121st American Optometric Association ("AOA") Meeting in Denver Colorado from June 20-24th. Eyecarrot will be showcasing the recently released Binovi Touch Saccadic Fixator in the Sports and Performance Vision Forum and will be exhibiting the Binovi Platform in the AOA Exhibit Hall.

"We are excited to be attending our first official AOA meeting since the development of the Binovi Platform. Our team has been working tirelessly to introduce and sign on practices across the USA, getting invaluable market data feedback, and working to supply the demand presented for the Binovi Touch hardware offering. The AOA meeting will be an opportunity to garner further insights from the thousands of Optometrists ("O.D.) attending the conference in Denver, and more importantly, bringing greater visibility to our World Class Binovi Platform," commented CEO Adam Cegielski.

About the American Optometric Association

The American Optometric Association is the leading authority on quality care and an advocate for our nation's health, representing more than 44,000 doctors of optometry (O.D.), optometric professionals and optometry students. Doctors of optometry take a leading role in patient care with respect to eye and vision care, as well as general health and well-being. As primary health care providers, doctors of optometry have extensive, ongoing training to examine, diagnose, treat and manage ocular disorders, diseases and injuries and systemic diseases that manifest in the eye. Doctors of optometry provide more than two-thirds of primary eye care in the U.S.

About Eyecarrot

Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp

 

Eyecarrot Announces Dr. Stefan Collier as an Advisor in Neurophotonics


Toronto, Ontario --June 12, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce the appointment of Dr. Stefan Collier as an Advisor in Neurophotonics; a field of study focusing on the use of photons or quantum units of light to study the brain and its processes at the cellular and molecular level. Dr. Collier is one of the leading minds in his field, having completed research in the subject going back 25 years. His previous work with the Binovi Touch Saccadic Fixator and other Wayne Engineering Products dates back over 30 years and sets the stage for exciting future developments with Eyecarrot. Dr. Collier has worked with professional sports for many decades, including world class athletes at the international Tennis level and Formula 1 racing teams.

"We are very excited to continue to expand the Eyecarrot team with the appointment of Dr. Collier. He has been recognized internationally for his contribution to the field of Functional Syntonic Optometry, speaks 7 languages, and will help the company in expanding the Binovi Platform globally, including Europe" commented Adam Cegielski, Eyecarrot CEO.

"I would like to commend the company on the recently released Binovi Touch Saccadic Fixator, the expansion of the Binovi Platform into Spain, and look forward to working with the Eyecarrot team" stated Dr. Stefan Collier, Eyecarrot Advisor.

About Dr. Stefan Collier, F.O., FCSO, CSO trustee, Dean BOAF

Dr. Stefan Collier is a leader in bringing functional optometry & Syntonics to Europe. He received from OEPF the Skeffington-Alexander International Award in 2010 and the Armand Bastien Award in 2002 and 2004. He received from (CSO) College of Syntonic Optometry the H. Riley Spitler Award in 2011. He received from (SOE) European Society of Optometrists the SOE Award in 2009.

Additional Awards:

2012 The Lifetime Achievement Award from Behavioral Optometry Academy Foundation BOAF
2014 The International Lifetime Achievement Award from OEPF
2015 The - Premio Robert y Linda Sanet- Award from SIODEC
2016 The Advancement of Neuro-Optometric Rehabilitation Award from NORA

About Eyecarrot

Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at http://www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Eyecarrot Innovations Corp

 

Eyecarrot Participates at the 48TH Annual College of Optometrists in Vision Development Meeting


Toronto, Ontario --May 31, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce its participation at the 48th Annual College of Optometrists in Vision Development "COVD" Meeting held at the Hyatt Regency Bellevue, in Bellevue, Washington. Eyecarrot was asked to educate COVD attendees on the future of vision therapy utilizing Binovi, while showcasing the Binovi Touch during an informative Exhibitor Seminar at the designated Eyecarrot booth.
Eyecarrot_Logo

Adam Cegielski, Eyecarrot's President and CEO Stated that "Eyecarrot, through its Binovi Platform, echoes the mission of the COVD: to drive progress through clinical excellence and research in developmental vision care, optometric vision therapy, and rehabilitation. Through multiple partnerships and future collaborations, this will result in greater education and a large adoption of optometric vision therapy, while increasing the recognition of its integral role in enhancing learning, productivity, and overall quality of life. We look forward to attending additional functions throughout 2018 and 2019 to reach clinicians across the globe and educating them on our world class platform."

About the College of Optometrists in Vision Development

The College of Optometrists in Vision Development (COVD) is a non-profit, international membership association of eye care professionals including optometrists, optometry students, and vision therapists. Established in 1971, COVD provides board certification for optometrists and vision therapists who are prepared to offer state-of-the-art services in: Behavioral and developmental vision care, Vision therapy, and Neuro-optometric rehabilitation. These vision care services develop and enhance visual abilities and correct many vision problems in infants, children, and adults. Vision care provided by all COVD members is based on the principle that vision can be developed and changed. Their mission is to improve lives by advancing excellence in optometric vision therapy and rehabilitation through education and board certification.

The COVD International Examination and Certification Board process includes a rigorous evaluation of the eye care professional's knowledge and abilities in providing developmental and behavioral vision care for patients. Optometrists who successfully complete their certification process are Board Certified in Vision Development and Vision Therapy and are designated Fellows of COVD (FCOVD). Vision therapists are certified to work with COVD Fellows as Certified Optometric Vision Therapists (COVT).

About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

T: (416)943-6271 l +1-855-416-7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp.

 

 

Eyecarrot Announces Shipment of its First 50 Binovi Touch Saccadic Fixator Units


Toronto, Ontario --May 23, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce the shipment of its first 50 Binovi Touch Saccadic Fixator units. After extensive development work, the release of the first 50 units represents a major milestone for the company. Eyecarrot showcased its hardware recently while participating at the International Sports Vision Association's annual show held in Utah and received feedback that helped drive the decision to ship the Binovi Touch to market.
Eyecarrot logo

The Wayne Saccadic Fixator has been the standard in sports performance and vision rehabilitation markets for over 40 years. With approximately 5000 traditional models currently in the market, extensive demand for the vast and various upgraded options, the company is excited to have shipped the first commercial units.

"We have entered into a new era of digital and connected health metrics, and we are extremely excited to have launched our Binovi Touch Saccadic Fixator in 2018. Our development team has ensured a smooth and stable release of a device that now improves upon 5 previous generations that go back many decades. The team is currently overwhelmed with demand while transitioning towards a much larger focus on commercialization," commented CEO Adam Cegielski.

Key differentiating features of the device include 49 tactile responsive buttons, multi- coloured button options; 4 LED Matrix displays, Bluetooth connectivity through the Binovi Touch mobile app; secure data connectivity to our Microsoft Azure API; a modular design that allows for scaling the size of the device; a weight of approximately 14kg (smallest and most robust in the market); and a price point that allows for accessibility in almost any vertical market imaginable. Research documenting the importance of saccadic eye movements will now increase by orders of magnitude with the release of a data connected Binovi Touch Saccadic Fixator. The company is in discussions with distributors in North America, Europe, Africa and Asia, as well as leading researchers from some of the best Universities in the world for a product that has unlimited potential to aid and assist in both vision and related symptom rehabilitation as well as vision enhancement for patients, athletes and students.

About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
T: (416) 943 6271 l 1-855 416 7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp

 

EYECARROT WITH KEYNOTE SPEAKER BRYCE SALVADOR PARTICIPATES AT THE INTERNATIONAL SPORTS VISION ASSOCIATION’S 2nd ANNUAL SHOW


Toronto, Ontario --May 16, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce its participation at the International Sports Vision Association’s 2nd annual show at the Zermatt Resort in Park City, Utah. Being a Platinum Sponsor of the event, Eyecarrot takes great pride in being able to contribute to such a tremendous association helping to further the importance of sports vision science. Eyecarrot invited Bryce Salvador to contribute as the keynote speaker of the event, relaying his personal message on the success and importance of sports vision. This discipline is helping all types of athletes reach higher levels of performance through the enhancement of their visual skills. Research now validates that Athletes who use their visual system to its maximum potential will increase overall performance, gain a competitive edge, and decrease their likelihood of suffering from concussions in the future.

As active participants during the show, Eyecarrot was able to demonstrate early prototypes of the Binovi Touch Saccadic Fixator with great success, receiving positive feedback from the sports vision marketplace.

“The field of sports vision science is still in its infancy. We are now in a time where testing, training, and most importantly data are front and centre to what athletes have access to in terms of performance enhancing tools. With the new Binovi Touch Saccadic Fixator, in tandem with the Binovi Touch Mobile First Multi Platform App, Bluetooth control, and connectivity to our Microsoft Azure API, we are significantly enhancing a tool that has been tried and tested since the 1970s, and will now provide measurable data on many of the most important vision skills used by athletes today” Commented CEO, Adam Cegielski.

About Special Advisor Bryce Salvador
Bryce Salvador is the former captain of the New Jersey Devils who has retired after playing 14 seasons in the NHL. He is also the CEO of xHockey Products, one of North America’s leading eCommerce and retailers of performance hockey equipment, products, and training aids. Through a partnership with the Rockets Sports Group, located in Bridgewater, NJ, Bryce looks to build a flagship center of excellence in the Northeast for sports performance.

Bryce Salvador stated, “I am excited to be a part of the Eyecarrot Team. After a cochlear concussion had left me sidelined for an entire hockey season, vision therapy along with sports vision training alleviated my visual symptoms and played a crucial role in my return to playing hockey in the NHL. Not only did the therapy help me recover from this injury, but it also enabled me to see the game in a way that I hadn’t before. In joining Eyecarrot, I have the opportunity to use my first-hand experience to contribute to the development of Eyecarrot’s high performance products for athletes and non-athletes alike”.

View Eyecarrot’s full blog on ISVA here: https://www.eyecarrot.com/blog/eyecarrot-at-isva/ 

About the International Sports Vision Association
ISVA is an organization open to Optometrists, Athletic Trainers, Therapists, Physicians, and Sports Teams. The focus of the ISVA organization is to help in the prevention of sports vision injuries, vision enhancement therapy, prevention and treatment of concussive injuries for athletes, contact lenses and other eyewear options for athletes.

The mission of the International Sports Vision Academy is based on three principles: Education, Outreach and Affiliation: Education is training Optometrists, Vision Therapists, Athletic Trainers, Athletes and other interested parties in the art and science of Sports Vision and the prevention of vision-related sports injuries. Outreach is reaching Athletes, coaches, trainers, families and other interested parties to be aware of the importance of vision in sports and be aware of the impact of enhancement of vision skills. Affiliation is working with other professional organizations to bring together like-minded organizations thereby creating a more robust educational experience.

About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Eyecarrot Innovations Corp.

 

Eyecarrot Announces Inclusion Into the Tormont50


Toronto, Ontario --May 15, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce joining the Tormont50 upon invitation by the Tormont Group. The Tormont 50 is a company investment platform limited to 50 companies targeting formation of an exchange traded fund "ETF".

Companies invited to the Tormont50 must demonstrate compelling reasons for investment, including but not limited to, undervaluation relative to peersnew and innovative/disruptive technologies or methods, management/board evolution, upcoming events likely to drive value appreciation which could enable an increase in market capitalization. The Tormont50 is introduced to companies and institutional investors providing relevant information for select top growth opportunities identified by Tormont Group in the North American small and microcap segment. Member companies are the upcoming new leaders in their segment, focused on new technologies, innovation, and disruption and is limited to a maximum of 50 Companies. Member Companies are showcased to over 60 currently subscribed institutional shareholders across North America.

"Inclusion in the Tormont50 is a testament to the work done by our team over the last 24 months. Our Binovi Platform will help transform how we advance the human visual system, and we are very pleased for this work to be recognized by The Tormont Group" commented Adam Cegielski, CEO.

About The Tormont Group

The Tormont Group is a collective of corporate advisory, marketing & digital media, and public relations experts. Their focus is assisting select companies in presenting a succinct and uniform message to the investor community and effectively communicating that message through the most efficient mediums available. The Corporate Advisory partnership collectively has over 80 years of success in portfolio management, M&A, investment banking and institutional sales. Tormont hosts an annual Tormont50 conference in which all member companies and institutional investors are invited. This event is an open forum for one-on one introductions and meetings between company and interested investors, as well as a relaxed venue for building company to company introductions and relationships. Guest speakers will discuss topics of relevance to the attendees and will include some of the investors subscribed to the platform. The Tormont50 conference an exclusive event and is not be extended to any entity outside the membership.

About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
T: (416) 943 6271 l 1-855 416 7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp

 

Eyecarrot Announces Educator Patricia Andrich as Advisor


Toronto, Ontario --May 08, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce the appointment of Patricia Andrich as Educational Advisor to Eyecarrot's Binovi Platform in the development of a world class library for advanced strategies in reflex integration. The appointment of Mrs. Andrich to the Advisory Team demonstrates Eyecarrot's commitment to the expansion and quality of educational material that the Binovi Platform offers. Mrs. Andrich is a leading therapist in the field of Functional Vision Development and will ensure the delivery of the highest quality of education from the therapist's point of view. In addition, she will lend critical insights to the successful implementation of Binovi into a variety of clinics worldwide.

Quote from Dr. Leonard Press about her Appointment . "I am delighted that Patti Andrich has joined the Eyecarrot/Binovi family as an advisor. She brings a wealth of experience in education and clinical practice, teaming with her spouse Dr. Alex Andrich in a highly successful practice that revolves around vision development neuro-optometric rehabilitation. Her presentations on primitive reflexes are highly regarded in our field by vision therapists and optometrists, and I look forward to the contributions that she will make to the Binovi Platform."

About Patti Andrich MA, OTR/L, COVT , INPP

Patti Andrich is an occupational therapist known for her success in treating individuals with difficulties in visual-motor, visual-perceptual, auditory perception and vestibular functioning. Patti received her Master degree from The Ohio State University College of Education and her occupational therapy degree from the Cleveland State University Department of Health Sciences. Additionally, Patti holds certification in auditory processing using The Listening Program with Bone Conduction from Advanced Brain Technologies and is certified in INPP primitive reflex integration techniques; having studied in England under the direction of Sally Goddard at the Institute of Neurological Physiological Psychology (INPP). Patti is a certified vision therapist, member of The Optometric Extension Program as well as the College of Optometrists in Vision Development, the recipient of several honors and awards and has been a guest speaker for local, state, national and international conferences.

About Eyecarrot

Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

On behalf of the Board of Directors
Adam Cegielski
President | CEO

Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at http://www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
T: +1(416)943-6271
+1-855-416-7158
info@eyecarrot.com

SOURCE Eyecarrot Innovations Corp


 

Eyecarrot Announces Closing Of Financing


Toronto, Ontario --May 01, 2018 -  Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC) is pleased to announce the closing of a previously announced non-brokered private placement for total proceeds of $718,010. The Company issued a total of 4,786,733 units at $0.15 per unit, each unit comprised of one common share of the Company (a "Share") and one transferable common share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the Company (a "Warrant Share") until April 28th, 2020 at a purchase price of $0.30 per Warrant Share.

Aggregate finder's fees of $10,500 in cash and 70,000 finder's warrants were paid to registrants. Each finder's warrant has the same terms as the warrants forming part of the units, provided that the finder's warrants are non-transferable.

All securities issued in connection with the Private Placement are subject to a four-month hold period expiring on August 27, 2018. Further restrictions may apply to certain subscribers under foreign securities laws.

Proceeds of the Placement are to be applied to general working capital.

About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system. Eyecarrot's objective is to help Optometrists and their teams manage a wide range of problems involving visual function. The building of this network will revolutionize human vision performance, and release the untapped potential of millions of people, globally.

On behalf of the Board of Directors
Adam Cegielski
President | CEO
Telephone: 1.855.416.7158 - 416.943.6271
Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Eyecarrot Innovations Corp

 

-------------------------------------------------------------------
About Eyecarrot Innovations Corp.:


We at Eyecarrot aspire for more: more for the doctor, more for the therapist, more for the patient, and more for the benefits of Vision Therapy.

Who is Eyecarrot?

Our sight is vital in how we view the world around us. Sight and vision allow us to connect with our surroundings, keep us safe, and helps maintain our sharpness of mind.

Eyecarrot is focused on the importance of vision. We have made vision therapy accessible through an improved technology that combines data, expert knowledge and insights of vision care professionals to help patients on a global scale — Binovi.

Binovi’s commitment will always be to maximize the collaboration between optometrists, therapists, and patients and their education.

Our Vision

We’ve designated the Binovi platform to serve as the foundation for constructive innovation within vision therapy. Our strategic approach sees us deliver a collaborative care system that integrates software, hardware, data and the expert knowledge and insights of vision care professionals.

Technology is rapidly changing the way businesses are operated, and we are building Binovi to apply this technology to the complexities of running a modern Vision Therapy Practice.

Our innovative platform that helps Optometrists treat vision issues with in-office therapy as well as home based activities.

Carrots are still good for the eyes, iPads are good for Optometrists and their teams, and over half of the world now has a smartphone and access to the Internet. We want to use our technology to empower the world to measure, exercise and evolve the entire Visual System – for the eyes, the brain and the body to work together in perfect harmony.

The Challenge: What You Don’t See

The Vision Care Industry is Primarily Focused on Visual Acuity and Disease Management.

The most commonly identified visual issues are treated with glasses, contact lenses, surgery, or medication, leaving many visual performance issues undiagnosed or mistreated.

There is little consideration given to options in helping advance human performance by treating visual issues connected to learning disabilities, amblyopia, strabismus, convergence insufficiency, brain injury and their related conditions.

It’s time to spread the message. Vision Therapy addresses all these issues and lets us penetrate beneath the surface. This means promise for huge gains in human performance, improvement in recovery of brain injuries, and less reliance on drugs to improve visual attention.

Our Solution: Binovi

A Spectrum of Possibilities.

Introducing BinoviTM from Eyecarrot — A collaborative care platform that integrates software, hardware, data and the expert knowledge and insights of vision care professionals.

This is the hub of your vision therapy management system. With Binovi Pro, vision care professionals can design and manage personalized vision therapy plans with simple, intuitive, drag-and-drop functionality. An inventory of explicit therapy procedures with clear content and illustrative videos empowers the therapist and patient to collaborate and communicate at an unprecedented level both within and outside the office and practice. Binovi Coach enables patients to manage and track their progress anywhere using their own smartphones.

We welcome you to the Eyecarrot community, and be prepared for the ride of your professional life through the exciting Binovi platform!

Our Binovi platform works together to give Optometrists, Therapists and Patients the type of experience they are used to receiving in the world we live in today!

We designed Binovi to help vision therapy teams move toward a paperless process for the delivery of home therapy activities. Therapist training and education, and the planning of weekly in-office vision therapy will streamline your business practice. The efficiencies of digitally prescribing activities, tracking of therapy compliance, and data capture gives insight into your patients’ therapy, allowing you to adjust and customize therapies specific to patient results and needs. Binovi offers you expert high-definition video instruction to promote better education and understanding for your care teams and patients.

With this system in place, you can design and manage personalized vision therapy plans with simple, intuitive, drag-and-drop functionality. An inventory of explicit therapy procedures with clear content and illustrative videos empowers the therapist and patient to collaborate and communicate at an unprecedented level both within and outside the office and practice.

A Purposeful and Powerful Tool for Vision Training and Vision Therapy

For Education, Sports, Healthy Aging and Rehabilitation

We have re-engineered the Wayne Saccadic Fixator —an industry standard for over three decades to measure and improve visual memory, reaction time and peripheral vision training— to integrate it with our Binovi platform. Currently used in over 1,500 practices and offices in over 20 countries, the all-new Binovi Touch is available now!

Wireless Control

Using Bluetooth wireless to sync to the Binovi Touch app, the new Binovi Touch is easy for you to control from your iPad.

Tried-and-tested activities from the Wayne Saccadic Fixator have been ported to the new Binovi Touch, making it easy to jump right in and start testing a number of key vision skills right away!

Rich Insights

Best-in-class charting and data visualization give you all the power and flexibility you need to analyze trends and progress over time.

Customizable tests can drill down into specific aspects of a patient’s vision skills, or can be broadened to get a bigger picture of how they are progressing.

Incredible New Features
We’ve re-engineering the new Binovi Touch with new technology, allowing for a greater range of activities.

New 49-light Array
Multi-colored lights with tactile response enable entirely new activities to increase cognitive and visual memory load for your patients.

LED-matrix displays
All new led-matrix displays power the next generation of accomodative rock activities for your patients

Customize and Create
Full control via Binovi Pro allows you to design custom activity sets, combining your favourite Touch activities with physical exercise routines into multi-disciplinary programs

Portable, Universal, Expandable

We’ve designed Binovi Touch to be as versatile as possible.

Portable
Built for endurance, yet light enough for you to carry.
Contact us for more information on recommended portable stands, mounting frames, and to order your custom carrying case.

Universal
Powered via usb so it’s easy to use, wherever you are in the world.
The Binovi Pro app is available in multiple languages.

Expandable (coming soon)
An ever-growing range of new accessories to be used with the new Touch are under development.
The Binovi open api integrates with certified 3rd-party devices

SOURCE: http://www.eyecarrot.com/




Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty-four hundred dollars for Eyecarrot Innovations Corp. coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Eyecarrot Innovations Corp.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.